NT-proBNP predicts short-term cancer diagnosis
José Tuñón1,2,3,4, Álvaro
Aceña1,2 , Ana
Pello1,2 , Sergio
Ramos-Cillán2, Juan
Martínez-Milla1,2 , Óscar
González-Lorenzo1,2 , Jesús
Fuentes-Antras5, Nieves
Tarín6 , Carmen
Cristóbal7,8 , Luis M.
Blanco-Colio3,4 , José Luis
Martín-Ventura2,3,4 , Ana
Huelmos9 , Carlos
Gutiérrez-Landaluce7, Marta
López-Castillo1,2 , Joaquín
Alonso8,10 , Lorenzo López
Bescós8 , Luis
Alonso-Pulpón2,11, Jesús
Egido2,3,12 , Ignacio
Mahíllo-Fernández13, Óscar
Lorenzo2,3,12
1 Department of Cardiology, IIS-Fundación
Jiménez Díaz, Madrid, Spain
2 Autónoma University, Madrid, Spain
3 Laboratory of Vascular Pathology,
IIS-Fundación Jiménez Díaz, Madrid, Spain
4CIBERCV, Madrid, Spain
5 Department of Oncology, Hospital Clínico
Universitario San Carlos, Madrid, Spain
6 Department of Cardiology, Hospital
Universitario de Móstoles, Madrid, Spain
7 Department of Cardiology, Hospital de
Fuenlabrada, Madrid, Spain
8 Rey Juan Carlos University, Alcorcón,
Madrid, Spain
9 Department of Cardiology, Hospital
Universitario Fundación Alcorcón, Madrid, Spain10 Department of Cardiology, Hospital de
Getafe, Madrid, Spain
11Department of Cardiology, Hospital Puerta de Hierro,
Madrid, Spain
12 CIBERDEM, Madrid, Spain
13 Research Unit, IIS-Fundación Jiménez Díaz,
Madrid, Spain